Lensar today entered into a priority credit line agreement in a move that analysts say casts doubt over its planned acquisition by Alcon.

Glaucoma Research Foundation (GRF) today announced a new partnership with Alcon, the global leader in eye care, to expand access to trusted, patient-centered glaucoma education for Spanish-speaking ...

Staar Surgical reported a $80.4M full-year loss and 23.7% revenue decline, with analysts maintaining hold ratings as the ...

Earnings, Dividend Proposal, and Board Change Put Alcon in Focus Alcon (SWX:ALC) is back on investors’ radar after its fourth quarter and full year 2025 results, a proposed 2025 dividend, and an ...

Why Alcon Stock Is On Investors’ Radar Today Alcon (SWX:ALC) is back in focus after recent share price moves, with the stock showing mixed returns across different time frames and attracting fresh ...

Align Technology, carrying a Zacks Rank #2 at present, posted a fourth-quarter 2025 adjusted EPS of $3.29, exceeding the ...

Alcon Laboratories, already one of the largest employers and taxpayers in Tarrant County, is exploring a major expansion of its Fort Worth campus. Alcon, which started in Fort Worth and has grown to ...

Alcon Entertainment “got its ass kicked” financially with the weak box office performance of “Transcendence,” the company’s top executive told TheWrap, saying that the company will lose at least $30 ...

When Novartis said in June that it would spin off its long-struggling eye-care unit, Alcon, CEO Vas Narasimhan declined to estimate what the valuation on such a transaction might be. But his ...